Humalog Mix 25 KwikPen Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per 100 IU/mL Insulin lispro 25%, insulin lispro protamine 75% (recombinant DNA origin)

Indications/Uses

Patients w/ DM who require insulin.

Click to view Humalog Mix 25 KwikPen detailed prescribing information

Dosage/Direction for Use

Individualised SC dosage.

Click to view Humalog Mix 25 KwikPen detailed prescribing information

Overdosage

View Humalog Mix 25 KwikPen overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food: Administer w/in 15 min before or immediately after meals.

Contraindications

Hypersensitivity to insulin lispro. Hypoglycemia.

Click to view Humalog Mix 25 KwikPen detailed prescribing information

Special Precautions

Do not administer IV. Transferring from other insulins. Illness or emotional disturbance that increases insulin requirements. Increased physical activity or diet changes. Hypoglycemia. Combination w/ thiazolidinediones. May affect ability to drive & use machines. Renal or hepatic failure. Pregnancy & lactation. Childn <12 yr.

Click to view Humalog Mix 25 KwikPen detailed prescribing information

Use In Pregnancy & Lactation

Click to view Humalog Mix 25 KwikPen detailed prescribing information

Adverse Reactions

Hypoglycemia. Inj site reactions eg, redness, swelling & itching, edema. Local & systemic allergic reaction.

Click to view Humalog Mix 25 KwikPen detailed prescribing information

Drug Interactions

Increased insulin requirements w/ corticosteroids, OCs or thyroid replacement therapy, danazol, β₂-stimulants. Decreased insulin requirements by oral hypoglycemic agent, salicylates, sulpha antibiotics, MAOIs, SSRIs, ACE inhibitors, angiotensin II receptor blockers (ARB), β-blockers, ocreotide or alcohol.

Click to view Humalog Mix 25 KwikPen detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Humalog Mix 25 KwikPen detailed prescribing information

Storage

View Humalog Mix 25 KwikPen storage conditions for details to ensure optimal shelf-life.

Description

View Humalog Mix 25 KwikPen description for details of the chemical structure and excipients (inactive components).

Action

View Humalog Mix 25 KwikPen mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Insulin Preparations

ATC Classification

A10AD04 - insulin lispro ; Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.

Regulatory Classification

Presentation/Packing

Form

Humalog Mix 25 KwikPen inj 100 IU/mL

Packing/Price

3 mL x 5 × 1's

Humalog Mix 25 KwikPen

insulin lispro + insulin lispro protamine

Manufacturer:

Eli Lilly

Distributor:

Zuellig Pharma